Calprotectin, a misnomer for another player in vascular calcification

Kidney Int. 2024 May;105(5):915-918. doi: 10.1016/j.kint.2023.11.016.

¹ Inserm Unit 1018, Team 5, Centre de Recherche en Épidémiologie et Santé des Populations (CESP), Hôpital Paul Brousse, Paris-Sud University (UPS) and Versailles Saint-Quentin-en-Yvelines University (Paris-Ile-de-France-Ouest University, UVSQ), Villejuif, France. Electronic address: tilman.drueke@inserm.fr.
² Inserm Unit 1018, Team 5, Centre de Recherche en Épidémiologie et Santé des Populations (CESP), Hôpital Paul Brousse, Paris-Sud University (UPS) and Versailles Saint-Quentin-en-Yvelines University (Paris-Ile-de-France-Ouest University, UVSQ), Villejuif, France; Department of Nephrology, Ambroise Paré University Hospital, Assistance Publique-Hôpitaux de Paris (APHP), Boulogne-Billancourt/Paris, France.

No abstract available

Keywords: RAGE; TLR4; calcification inhibitors; calcification promoters; chronic kidney disease; vascular calcification.

MeSH terms